"Vaccine immunotherapy for immune suppressed patients"

Details for Australian Patent Application No. 2012200672 (hide)

Owner IRx Therapeutics, Inc

Inventors Hadden, John W.

Agent Lord and Company

Pub. Number AU-A-2012200672

Parent 2004271930

Filing date 6 February 2012

Wipo publication date 1 March 2012

International Classifications

A61P 35/00 (2006.01) Antineoplastic agents

A61K 38/19 (2006.01) Medicinal preparations containing peptides - Cytokines

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61K 39/39 (2006.01) Medicinal preparations containing antigens or antibodies - characterised by the immunostimulating additives, e.g. chemical adjuvants

C12N 5/00 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines

C12N 15/19 (2006.01) Mutation or genetic engineering - Interferons

C12P 21/08 (2006.01) Preparation of peptides or proteins - Monoclonal antibodies

Event Publications

23 February 2012 Complete Application Filed

1 March 2012 Application Open to Public Inspection

  Published as AU-A-2012200672

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2012200673-Barrier

2012200671-Airborne Electromagnetic Time Domain System, Computer Product and Method